Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’ll be crying tears of joy soon. Don’t know about you but that’s what I’ll be doing.
If you don't laugh, you have to cry, after 7+ years in this stock.
You’ve got the “Bull” part right. Scramble the last three letters and add a “T” and you’ll be on target.
Those recent hopeful rumors about IPIX may also be greatly exaggerated.
Lolololololololololol this is comedy now.
That which is dead may never die.
Strong resistance w/ supporting upper long wick bearish candle immediately left - Complete market rejection- Below a nickel. No ongoing clinical trials to propel the stock w/ massive dilution ahead. Leo sitting on his ass. Shareholders left out to dry. Bearish as it gets.
IPIX Chart looking Bullish:
https://schrts.co/QRIuFjHC
Tecovirimat/excellent example of NIAID's drug development capability
"TPOOX.tecovirimat the only drug approved for smallpox seems to be the only other antiviral being studied for monkeypox besides Brilacidin."
From your very own link:
"Was the buy volume higher than the sell volume?"
Maybe.
I was responding to this statement by DaGreekster (not disagreeing with it):
"Today is the first time in a while that the Buy volume has exceeded the Sell volume as it is shown on our IPIX trades board. A unique day and hope its a trend to come."
I referred DaG to the Buy/Sell definitions on the IPIX trades board.
You tell me: What were the buy and sell volumes for IPIX shares yesterday and what source are you using for the information?
TPOOX.tecovirimat the only drug approved for smallpox seems to be the only other antiviral being studied for monkeypox besides Brilacidin.
The FDA is looking at very few options for treating the current viral epidemic of monkey pox as welll as other viral disorders.
https://clinicaltrials.gov/ct2/results?cond=monkeypox&term=&cntry=&state=&city=&dist=
https://www.niaid.nih.gov/diseases-conditions/monkeypox-treatment
Good luck,
Farrell
Was the buy volume higher than the sell volume? Of course it was.Nothing to do with how Ihub extrapolated the buy sells. Ridiculous argument.
"the market maker book positions play a role as does availability of supply above the current price."
Those things have nothing to do with the way Ihub determines whether they consider a trade to be a Buy or a Sell.
One more time:
"Trade definitions are based on the mid-price and are indicative only"
Further, the market maker book positions play a role as does availability of supply above the current price.
If buying volume had not been higher than the selling volume then why would the price increase by 14%.
"Today is the first time in a while that the Buy volume has exceeded the Sell volume as it is shown on our IPIX trades board."
I think that this explanation, provided with the Ihub trades table, is crucial to understanding what they mean when they say "Buy":
"Trade definitions are based on the mid-price and are indicative only"
In other words they call certain trades buys and other trades sells based solely on whether they were executed above or below the average of the Bid and Ask prices....there's no real basis for the distinctions, just a mathematical one.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-qb-IPIX/trades
Buy vs. Sell volume. Today is the first time in a while that the Buy volume has exceeded the Sell volume as it is shown on our IPIX trades board. A unique day and hope its a trend to come. Looks like some end-of-day window dressing to boot.
The obvious is what the government could do for Ipix both scientifically and fiscally. The obvious is Ipix has a chance to be successful with Brilacidin because of that help. The obvious is Ipix is beaten down but far from out.
What fake news? I see posters who are bullish and those who are bearish. I for one like the fact that B is still being tested by the NIH for it's anti-viral properties and that a payer analysis was completed.
What it shows is if Ipix wraps a deal, as is possible at any time, the first flip will likely be to 40 cents.
"IPIX will explode upwards with all the news about to be unleashed. "
And when will that be?
Explode to what?
My guess is it will implode (under a penny) as soon as the they unload their shares. In the meantime, I expect the fake news will continue.
Agree 100%. IPIX will explode upwards with all the news about to be unleashed.
*B426*
The claim made that IPIX is "Dead" is false. Many exciting things are happening with this company, and there's never been a better time to invest, imo.
"The centers will initially focus on novel, oral antivirals for SARS-CoV-2 and other coronaviruses", so they won't involve Brilacidin.
Aerosol application will be looked at hard by the government scientific researchers. Most likely being tested free of charge at this very moment.
*B426*
Before NIAID can do B-AV P-2, they will have to decide what is the best delivery method (pill/tablet/aerosol) for B-AV.
"The centers will initially focus on novel, oral antivirals for SARS-CoV-2 and other coronaviruses and will expand to other pathogens of pandemic concern in future years."
Oral will not work for Brilacidin antivirus in my opinion CallMeCrazy. It is one of the many safety strengths in Brilacidin. Brilacidin does not go into the blood from the stomach and intestines. It is why mucositis and all intestinal problems are great potential value for Brilacidin.
But inhalation or nasal or intra-musculaire dosage of Brilacidin for antivirus is very possible and I know Ipix works on this.
NIAID's Antiviral Program for Pandemics (APP) And Brilacidin
All the FREE US GOVERNMENT testing being gifted to IPIX is definitely rubbing some the wrong way. Sad to believe some gleefully pray that the drug fails all the 22 plus trials being conducted by the researchers. *B426* must fail all trials to make some emotionally happy despite their desired results leads to the inflicted individuals of these ailments suffering through life.
*B426*
Frenchbroad.......... Here is a current Chart on IPIX..... The 9 SMA has broken thru the 21 SMA, and the Macd is marching North for momentum....... This is a CURRENT chart...............
https://schrts.co/fmZACVqu
"When I or anyone log on to this message board the first thing to see is a chart for Ipix only from 2014 to today."
Not so......I don't see it and you don't have to either.
This better?
https://investorshub.advfn.com/uimage/uploads/2022/8/14/bumckScreen_Shot_2022-08-14_at_9.03.52_PM.png
I think everyone will tell you the USA government is the best judge in the world for human drug safety and effectiveness.
We will see what they can discover with their investment in Brilacidin.
...and as we all know, the government never throws money away...
I can watch for Alfasigma Brilacidin news to swirl next week.
The USA government certainly does not think Ipix is dead company with a failed pipeline. They invest a lot of time and money in wee Ipix and Brilacidin.
NIH is paying for research to test Brilacidins anti-viral potential. Latest testing is on the Monkeypox virus.
"Brilacidin has consistently inhibited all coronaviruses tested, independent of cell type, at generally attainable systemic concentrations (based on established human pharmacokinetics of IV-administered Brilacidin)".
Go killer B, too bad coronavirus.
The progress in the science, along with the financial and corporate governance conditions, got the "shareholders or people who think to buy some of the company" to where they are today:
$0.042 US.
Investors new and old:
Ignore the non-science elements at your peril, if that's what you choose to do.
While the pit remains the same...
There is also a lot of good independent information on the science of Ipix here:
https://www.google.com/search?client=firefox-b-1-d&q=google+scholar+brilacidin
and here:
https://www.google.com/search?client=firefox-b-1-d&q=google+scholar+kevetrin
And of course for a small biotech like Ipix the science is the most important part for shareholders or people who think to buy some of the company.
"There is an abundance of great information on the Innovation Pharmaceuticals website. Check it out and make your own investment decision. Best to all IPIX investors!"
New investors should also be aware that they're only getting one side of the story on the website. You would be wise to supplement that information with the SEC filings that can be found at SEC.gov and the Nevada filings (if and when they get around to updating them, which will hopefully occur before the company has its Charter revoked in a few weeks).
NRS Chapter 78
The turd swirls.
The pendulum swings.
Ehrlich and IPIX have been the walking dead for the past seven years, providing nothing of value during that time but flopping around bumping into wall after wall.
Exaggerated in the sense the CEO and his cronies will continue to suck shareholders dry for years to come maybe.
The rumors of IPIX death are greatly exaggerated. Go IPIX!
Reality. Dead at 4 pennies.
Up 300% since the lows. The front side of that chart would have shown IPIX at a few dimes to a climb of $4.97. Fantastic run.
Followers
|
976
|
Posters
|
|
Posts (Today)
|
5
|
Posts (Total)
|
403539
|
Created
|
05/10/08
|
Type
|
Free
|
Moderators zandant sunspotter snayeman loanranger frenchbroad |
Innovation Pharmaceuticals Inc. (IPIX)
$IPIX NEWS - http://ipharminc.com/press-release
SEC Filings https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
From the most recent 10-K:
There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.
We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.
http://www.ipharminc.com/
About Innovation Pharmaceuticals Inc.:
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.
IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
More information is available at http://www.ipharminc.com.
Management: http://www.ipharminc.com/senior-management/
Scientific Advisors: http://www.ipharminc.com/scientific-advisors/
Clinical Trials: https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Product Pipeline: http://www.ipharminc.com/therapeutic-areas/
Recent News and Press Releases:
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/
SEC Filings (CIK:0001355250): https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com
Share Structure: See SEC filing link above for current share structure
Investor Relations:
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1
Chart: https://stockcharts.com/h-sc/ui?s=IPIX
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |